ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Delayed Data
As of May 26
 +0.26 / +1.63%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 31.00, with a high estimate of 37.00 and a low estimate of 20.00. The median estimate represents a +91.12% increase from the last price of 16.22.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Hold stock in ACADIA Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 65.06%
Growthannually -33.22%


Growthquarterly 13.03%
Growthannually 9.93%
Key to the earnings and sales forecast charts.